Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis
Hien Thi Thu Le, Akshaya Murugesan, Thiyagarajan Ramesh, et al.
International Journal of Biological Macromolecules (2021) Vol. 189, pp. 142-150
Open Access | Times Cited: 13

Showing 13 citing articles:

Programmed cell death detection methods: a systematic review and a categorical comparison
Sana Kari, Kumar Subramanian, Ilenia Agata Altomonte, et al.
APOPTOSIS (2022) Vol. 27, Iss. 7-8, pp. 482-508
Open Access | Times Cited: 189
Cadmium in food: Source, distribution and removal
Ruoyu Wang, Panting Sang, Yahui Guo, et al.
Food Chemistry (2022) Vol. 405, pp. 134666-134666
Closed Access | Times Cited: 124
Application of molecular dynamics simulation in self-assembled cancer nanomedicine
Xueli Xu, Ao Liu, Shuangqing Liu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Purinergic signaling: Diverse effects and therapeutic potential in cancer
Jasmeet Kaur, Sanchit Dora
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Anticancer Activity of Mannich Bases: A Review of Recent Literature
Gheorghe Roman
ChemMedChem (2022) Vol. 17, Iss. 16
Closed Access | Times Cited: 23
Bischalcone derivatives with fluorine and methoxy functional groups: Synthesis, molecular docking, and biological evaluation as potential anticancer agents
Şeyda Özcan, Derya Aktaş Anıl, Gözde Yalçın, et al.
Journal of Molecular Structure (2025) Vol. 1329, pp. 141468-141468
Closed Access
The P2 purinoceptors in prostate cancer
Zilin Wang, Sha Zhu, Sirui Tan, et al.
Purinergic Signalling (2022) Vol. 19, Iss. 1, pp. 255-263
Open Access | Times Cited: 14
Adenosine triphosphate induced cell death: Mechanisms and implications in cancer biology and therapy
Hao-Ling Zhang, Doblin Sandai, Zhong-Wen Zhang, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 12, pp. 549-569
Open Access | Times Cited: 5
Advances in structure-based drug design targeting membrane protein markers in prostate cancer
J.P. Batista-Silva, Diana Gomes, Sérgio F. Sousa, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104130-104130
Open Access | Times Cited: 1
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer
Hien Thi Thu Le, Akshaya Murugesan, Nuno R. Candeias, et al.
APOPTOSIS (2022) Vol. 27, Iss. 3-4, pp. 283-295
Open Access | Times Cited: 3
Extracellular ATP Induced S-Phase Cell Cycle Arrest via P2Y Receptor-Activated ERK Signaling in Poorly Differentiated Oral Squamous Cell Carcinoma SAS Cells
Chia Chih Lau, Amnani Aminuddin, Kok Meng Chan, et al.
Life (2021) Vol. 11, Iss. 11, pp. 1170-1170
Open Access | Times Cited: 4
GPCR genes as a predictor of glioma severity and clinical outcome
Eun‐A Ko, Tong Zhou
Journal of International Medical Research (2022) Vol. 50, Iss. 7
Open Access | Times Cited: 2
Immunomodulatory and Apoptotic Effect of Cinnamaldehyde in HepG2 Cells
Haripriya Dayalan, Santhosh Arul, Giridharan Bupesh, et al.
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 4, pp. 320-320
Open Access | Times Cited: 2
Page 1

Scroll to top